Related Experiment Video
Updated: Jun 13, 2026
09:27
Functional Complementation Analysis (FCA): A Laboratory Exercise Designed and Implemented to Supplement the Teaching of Biochemical Pathways
Published on: June 24, 2016
Structure-function relationships and clinical applications of L-asparaginases
N E Labrou1, A C Papageorgiou, V I Avramis
1Laboratory of Enzyme Technology, Department of Agricultural Biotechnology, Agricultural University of Athens, Iera Odos 75, 11855-Athens, Greece. Lambrou@aua.gr
Current Medicinal Chemistry
|April 29, 2010
Summary
L-asparaginase (L-ASNase) treats blood cancers by breaking down L-asparagine. Different bacterial sources yield L-ASNase with varying properties, impacting efficacy and side effects in patients.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- L-asparaginase (L-ASNase) is crucial for treating hematologic malignancies like acute lymphoblastic leukemia (ALL).
- Therapeutic L-ASNase originates from various bacterial sources, notably E. coli and Erwinia chrysanthemi.
- Different L-ASNase preparations exhibit distinct biochemical, pharmacokinetic, and immunogenic profiles, influencing clinical outcomes and side effects.
Purpose of the Study:
- To review biochemical and pharmacokinetic data of therapeutic bacterial L-asparaginases.
- To detail the structure, function, and clinical applications of these enzymes.
- To elucidate how enzyme properties influence therapeutic efficacy and side effects.
Main Methods:
- Literature review of existing biochemical and pharmacokinetic studies.
- Comparative analysis of structural, physicochemical, and kinetic properties of L-ASNases from different sources.
- Synthesis of information on clinical applications and observed side effects.
Main Results:
- Bacterial L-ASNases possess diverse properties stemming from their source-specific structures.
- These variations directly correlate with differences in enzyme activity, stability, immunogenicity, and toxicity.
- Understanding these differences is key to predicting enzyme behavior and patient response.
Conclusions:
- Variations in L-ASNase structure and function necessitate careful selection of enzyme preparations for optimal therapeutic benefit.
- Further research into L-ASNase mechanisms can guide the development of improved enzyme variants with enhanced efficacy and reduced toxicity.
- Detailed knowledge of L-ASNase properties is essential for personalized treatment strategies in hematologic cancers.
Related Concept Videos
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...